[HTML][HTML] Rethinking next-generation vaccines for coronaviruses, influenzaviruses, and other respiratory viruses

DM Morens, JK Taubenberger, AS Fauci - Cell host & microbe, 2023 - cell.com
Viruses that replicate in the human respiratory mucosa without infecting systemically,
including influenza A, SARS-CoV-2, endemic coronaviruses, RSV, and many other" …

Immune imprinting and next-generation coronavirus vaccines

CQ Huang, S Vishwanath, GW Carnell, ACY Chan… - Nature …, 2023 - nature.com
Vaccines based on historical virus isolates provide limited protection from continuously
evolving RNA viruses, such as influenza viruses or coronaviruses, which occasionally spill …

A functional group–guided approach to aptamers for small molecules

K Yang, NM Mitchell, S Banerjee, Z Cheng, S Taylor… - Science, 2023 - science.org
Aptameric receptors are important biosensor components, yet our ability to identify them
depends on the target structures. We analyzed the contributions of individual functional …

Single-cell BCR and transcriptome analysis after influenza infection reveals spatiotemporal dynamics of antigen-specific B cells

NR Mathew, JK Jayanthan, IV Smirnov, JL Robinson… - Cell reports, 2021 - cell.com
B cell responses are critical for antiviral immunity. However, a comprehensive picture of
antigen-specific B cell differentiation, clonal proliferation, and dynamics in different organs …

Is a universal influenza virus vaccine possible?

R Nachbagauer, P Palese - Annual review of medicine, 2020 - annualreviews.org
Influenza viruses remain a severe burden to human health because of their contribution to
overall morbidity and mortality. Current seasonal influenza virus vaccines do not provide …

Limited access to antigen drives generation of early B cell memory while restraining the plasmablast response

V Glaros, R Rauschmeier, AV Artemov, A Reinhardt… - Immunity, 2021 - cell.com
Cell fate decisions during early B cell activation determine the outcome of responses to
pathogens and vaccines. We examined the early B cell response to T-dependent antigen in …

[HTML][HTML] A Research and Development (R&D) roadmap for influenza vaccines: Looking toward the future

KA Moore, JT Ostrowsky, AM Kraigsley, AJ Mehr… - Vaccine, 2021 - Elsevier
Improved influenza vaccines are urgently needed to reduce the burden of seasonal
influenza and to ensure a rapid and effective public-health response to future influenza …

Allelic polymorphism controls autoreactivity and vaccine elicitation of human broadly neutralizing antibodies against influenza virus

M Sangesland, AT de la Peña, S Boyoglu-Barnum… - Immunity, 2022 - cell.com
Human broadly neutralizing antibodies (bnAbs) targeting the hemagglutinin stalk of group 1
influenza A viruses (IAVs) are biased for IGHV1-69 alleles that use phenylalanine (F54) but …

First exposure to the pandemic H1N1 virus induced broadly neutralizing antibodies targeting hemagglutinin head epitopes

JJ Guthmiller, J Han, L Li, AW Freyn, STH Liu… - Science translational …, 2021 - science.org
Broadly neutralizing antibodies are critical for protection against both drifted and shifted
influenza viruses. Here, we reveal that first exposure to the 2009 pandemic H1N1 influenza …

[HTML][HTML] Polyreactive broadly neutralizing B cells are selected to provide defense against pandemic threat influenza viruses

JJ Guthmiller, LYL Lan, ML Fernández-Quintero, J Han… - Immunity, 2020 - cell.com
Polyreactivity is the ability of a single antibody to bind to multiple molecularly distinct
antigens and is a common feature of antibodies induced upon pathogen exposure …